` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE.

Slides:



Advertisements
Similar presentations
HIV TB. World wide TB is the most common cause of death in people with HIV About 1/3 of HIV infected people worldwide are co-infected with TB (co-infection.
Advertisements

Pulmonary Tuberculosis.
Dr. Essam El Moghazy NTP Egypt
Number of specimens tested
Contact Evaluation Your name Institution/organization Meeting Date International Standard 16.
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Your name Institution/organization Meeting Date. Introduction.
Performance of a diagnostic test
Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.
Nick Curry, MD, MPH Infectious Diseases Prevention Section
Contact Investigation for Tuberculosis Control
Implementing NICE guidance
Nodules and infiltrates
Molecular testing for detection of Mycobacterium tuberculosis San Francisco Department of Public Health Laboratory.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
New approaches in TB diagnosis and treatment Prof. M.A. Tageldin.
THE YIELD OF GENEXPERT IN PULMONARY TUBERCULOSIS&RIFAMPICIN RESISTANCE
National Tuberculosis Controllers Association
Tuberculosis Control Dr. Yeşim YASİN Fall-2013.
Delayed TB Diagnosis Thomas R. Navin MD
Ruqaya Mustafa Ali Genetic Engineering and Biotechnology.
Lecture 3 Validity of screening and diagnostic tests
TREATMENT OF TUBERCULOSIS, 2003
Country Update: Tuberculosis in Thailand
World Tuberculosis Day 2013 TB situation in 2011: Findings from the ECDC and WHO/EURO joint TB surveillance report ECDC TB Team European Centre for Disease.
BACKGROUND LOW INCOME COUNTRY TUBERCULOSIS ♂>♀ A I M 1.Identify gender based differences in patients with Pulmonary Tb 2. Use this information to improve.
Let’s take a 15 minute break Please be back on time.
Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie.
World Health Organization TB Case Definitions
Nucleic Acid Amplification Test for Tuberculosis
SMEAR NEGATIVE TUBERCULOSIS
Molecular Diagnosis of Infectious Diseases. Why use a molecular test to diagnose an infectious disease? Need an accurate and timely diagnosis Important.
Diagnosis of TB.
Unit 5: IPT Isoniazid TB Preventive Therapy
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
1 Tuberculosis: Basics Rick Speare Anton Breinl Centre School of Public Health, Tropical Medicine and Rehabilitation Sciences James Cook University 16.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Tuberculosis: A disease caused by tiny germs that enter in lungs when someone breath them in. Mycobacterium tuberculosis is a rod shaped, non motile,
PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO- INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA. Enya V.N.V, Onubogu C.C., Wahab.
Revision of new diagnostics for TB
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Journal club Diagnostic accuracy of Urinalysis for UTI in Infants
Sunil Kumar, B.K.Kapoor, Urvinderpal Singh, Vidhu Mittal Department of Pulmonary Medicine, GMC,Patiala PRESENTATION OF PULMONARY TUBERCULOSIS IN ELDERLY.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
EBM Appraisal (Diagnostics). Clinical Scenario You are the duty resident at the traige on a Sunday afternoon when... a 3 year old Male came with a chief.
Dr Justin O’Grady. Zambia is a high burden TB and high HIV setting 44,154 TB cases notified in 2010 – incidence of 462/100,000 pop Approx 48% of pulmonary.
Diagnosis of pulmonary tuberculosis
Roundtable. Detection and treatment of TB Andrew Black.
Optimization of Sputum Smear for Detection of TB: A Prospective Blinded Evaluation Joy Sarojini Michael, Kalaiselvan S, Peter Daley, Lois Armstrong, Shalini.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS Identification of Mycobacterium tuberculosis complex in clinical specimens of HIV-infected patients at Instituto.
TB – LABORATORY INVESTIGATIONS by Dr. Zubaidah Abdul Wahab Datin Dr. Ganeswrie Raj 1.
CASES OF PLEURAL EFFUSION (n=56)
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
This is an archived document.
Dr Dawood Quiz questions.
Nucleic Acid Amplification Test for Tuberculosis
PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
Presentation 10 Analysing results and defining cases
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Indian Scenario HIV Situation TB Situation
Utilization of Audio visual medium for conveying sputum collection instructions for tuberculosis diagnosis Presenter: Fred ORINA.
Presentation transcript:

` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE PATIENTS.

TB- HIV CO-INFECTION Prevalence of pulmonary TB in HIV positive patients in India 10-15 percent in patients without respiratory symptoms 20-30 percent in patients with respiratory symptoms (1) HIV patient has 50 % lifetime risk of developing tuberculosis as compared to 10 percent in HIV negative person in India (1) 1. The situation of HIV/M.Tuberculosis Co-infection in India. P.Seth.The open Infectious Disease Journal .2011;5:51-59

Performance of Sputum Microscopy in HIV patients Poor sensitivity (35%-50 %) of sputum microscopy in HIV patients due to lesser number of cavities. (1) Need for alternative measures : Rule based tests NAAT Culture 1. Diagnosis and treatment of TB in HIV patients. C.Padmapriyadrshini et al. IJMR.201;130:850-65

Detection of pulmonary tuberculosis in HIV patients WHO : CBNAAT RNTCP : Sputum Microscopy

Performance of CBNAAT in HIV patients CBNAAT : Real-time PCR assay , cartridge based ,no processing needed, sensitive as well as specific

Evidence for CBNAAT in HIV patients

Aims and objectives To find out comparative accuracy of CBNAAT and sputum microscopy in HIV positive patients To find out prevalence of Rifampicin Ressistance in HIV positive patients Meta-analysis of CBNAAT in HIV patients incorporating our data and new studies missed by cochrane review.

Methodology . We assessed HIV positive adults referred to with pulmonary symptoms suggestive of tuberculosis . two sputum samples for microscopy using ZN stain ,one sputum sample for CBNAAT and one sputum sample for BACTEC based culture in each patient

Methodology . Using BACTEC culture positive as gold standard, we determined comparative sensitivity, specificity,Positive Predictive Value, Negative Predictive value, Positive Likelihood Ratio and Negative Likelihood Ratio of CBNAAT and sputum microscopy using SPSS 15.0 software . . We also did a meta-analysis combining various studies across the world with our study to determine pooled test performance of CBNAAT using MetaDisc 1.4 software.

Results :Sputum microscopy . Out of 100 screened patients ,90 included with adequate sputum volume, 33 were culture positive and 57 were culture negative

Results :sputum microscopy

Results :CBNAAT

Results :CBNAAT CBNAAT picked up 14 extra cases missed by Sputum microscopy. 2/29 patients were Rifampicin ressistant

Comparative Accuracy :ROC curves

Comparative Accuracy :ROC curves

Meta-analysis of Evidence

Meta-analysis of Evidence

Meta-analysis of Evidence

Conclusion CBNAAT performs better than sputum microscopy in diagnosis of pulmonary tuberculosis in HIV patient CBNAAT can tell about Rifampicin Ressistance Quickly CBNAAT has proved superior to sputum microscopy in cochrane review and meta-analysis done by us CBNAAT is recommended as first line modality for diagnosis of tuberculosis in HIV patients and re-treatment cases. CBNAAT is an add-on in diagnosis of pulmonary tb in HIV negative smear negative cases with suspicion of kochs chest

Case : Utility of negative CBNAAT A 40 year old HIV positive male presents with cough for two weeks , sputum AFB – 1+, CBNAAT negative

Case : Utility of negative CBNAAT

Case : Utility of negative CBNAAT Diagnosis : Atypical Mycobacterial infection.